natgillin/translations-raw huggingface dataset:
The solution should be inspected visually prior to use.
Raztopino morate pred uporabo vizualno pregledati.
Amyvid contains ethanol and sodium
Zdravilo Amyvid vsebuje etanol in natrij
Some accumulation/excretion is also observed in the urinary bladder.
Nekaj kopičenja/izločanja so opazili tudi v sečnem mehurju.
Negative scans have more activity in white matter than in grey matter, creating clear grey-white contrast.
Pri negativnih rezultatih preiskave je aktivnost večja v beli kot v sivi možganovini, kar ustvari jasen sivo bel kontrast.
The nuclear medicine doctor will only give this medicine during pregnancy if a benefit is expected which would outweigh the risks.
Če ste noseči Zdravnik nuklearne medicine vam bo to zdravilo med nosečnostjo dal samo, če pričakovane koristi odtehtajo tveganja.
What Amyvid is and what it is used for What you need to know before Amyvid is used How Amyvid will be used Possible side effects
Kaj je zdravilo Amyvid in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Amyvid Kako uporabljati zdravilo Amyvid
The injection of florbetapir (18F) must be intravenous in order to avoid irradiation as a result of local extravasation, as well as imaging artefacts.
Injiciranje florbetapirja (18F) mora biti intravensko, da ne pride do obsevanja, ki je posledica lokalne ekstravazacije, ali do artefaktov pri slikanju.
The effective dose resulting from the administration of a 370 MBq dose for an adult weighing 70 kg is about 7 mSv.
Učinkoviti odmerek po dajanju odmerka 370 MBq pri odraslem, ki tehta 70 kg, je približno 7 mSv.
The design of this study does not allow estimating the risk of MCI progression to clinical AD.
Zasnova te študije ne omogoča ocene tveganja za napredovanje zmerne kognitivne okvare v klinično AB.
5 How Amyvid is stored Contents of the pack and other information
5 Shranjevanje zdravila Amyvid Vsebina pakiranja in dodatne informacije
This medicinal product contains up to 37 mg sodium per dose.
To zdravilo vsebuje do 37 mg natrija na odmerek.
Elimination occurs primarily by clearance through the liver and excretion into the gallbladder and the intestines.
Izločanje poteka predvsem z očistkom prek jeter in izločanjem v žolčnik in prebavila.
Adjunctive use of quantitative information for image interpretation The feasibility and reliability of using CE-marked quantitative software as an adjunct to clinical qualitative interpretation was investigated in two studies using three different commercially available quantitative software packages.
Izvedljivost in zanesljivost uporabe kvantitativne programske opreme z oznako CE kot dodatek klinični kvalitativni interpretaciji so raziskovali v dveh študijah z uporabo treh različnih komercialno dostopnih paketov kvantitativne programske opreme.
If the administration is considered necessary, breast-feeding should be interrupted for 24 hours and the expressed feeds discarded.
Če je uporaba nujna, je treba dojenje prekiniti za 24 ur, izločeno mleko pa zavreči.
Appropriate aseptic precautions should be taken.
Treba je upoštevati ustrezne ukrepe za zagotavljanje aseptičnih pogojev.
Positive scans will have either: a) Two or more brain areas (each larger than a single cortical gyrus) in which there is reduced or absent grey-white contrast.
a) dve ali več območij v možganih (vsa večja od ene kortikalne vijuge) z zmanjšanim ali odsotnim sivo-belim kontrastom.
PETNET Solutions (Siemens Healthcare Limited), Nottingham, NG5 1PB, United Kingdom PETNET Solutions (Siemens Healthcare Limited), Northwood, HA6 2RN, United Kingdom PETNET Solutions, 91090, Lisses, France
PETNET Solutions (Siemens Healthcare Limited), Nottingham, NG5 1PB, Velika Britanija PETNET Solutions (Siemens Healthcare Limited), Northwood, HA6 2RN, Velika Britanija PETNET Solutions 91090, Lisses, Francija
The activity of florbetapir (18F) has to be measured with an activimeter (dose calibrator) immediately prior to injection.
Aktivnosti florbetapirja (18F) je treba meriti z merilnikom aktivnosti (kalibratorjem odmerka) tik pred injiciranjem.
Paediatric population There is no relevant use of Amyvid in the paediatric population.
Smotrne uporabe zdravila Amyvid pri pediatrični populaciji ni.
average reader accuracy on the scans with autopsy standard of truth improved from 90.1% at baseline to 93.1% (p-value <0.0001), with no observed decrease in either sensitivity or specificity.
Med vsemi sodelujočimi odčitovalci, ki so imeli dostop do kvantitativnih podatkov, se je povprečna natančnost odčitovalca pri posnetkih z obdukcijskim standardom resnice povečala z 90,1 % v izhodišču na 93,1 % (vrednost p <0,0001), brez opaženega upada občutljivosti ali specifičnosti.
Fertility No studies on fertility have been performed.
Študije plodnosti niso bile opravljene.
It is not known whether florbetapir (18F) is excreted in human milk during breast-feeding.
Ni znano, ali se florbetapir (18F) med dojenjem izloča v materino mleko.
The estimated absorbed radiation doses to organs and tissues of an average adult patient (70 kg) per 370 MBq of florbetapir (18F) using standard methods for dosimetry calculations (ICRP Volume 30) is tabulated below.
Odmerek sevanja, ki ga absorbirajo organi in tkiva povprečnega odraslega bolnika (70 kg) pri 370 MBq florbetapirja (18F), ocenjen z uporabo standardnih metod dozimetričnih izračunov (ICRP, 30. del), je prikazan v spodnji tabeli.
• The material should include Amyvid PET demonstration cases with correct PET scan interpretation by an experienced reader; Amyvid-PET scans for self-assessment; and a selfqualification procedure to be offered to each trainee.
• Material mora vključevati demonstracijske primere PET-posnetkov z zdravilom Amyvid s pravilno interpretacijo PET-preiskave s strani izkušenega odčitovalca, PET-preiskave z zdravilom Amyvid za samoocenjevanje in postopek samokvalifikacije, ki se ponudi vsakemu udeležencu izobraževanja.
A pivotal study in 59 end-of-life patients was aimed at establishing the diagnostic performance of Amyvid to detect the cortical neuritic plaque density (no or sparse vs. moderate or frequent).
Ključna študija, ki je vključevala 59 bolnikov ob koncu življenja, je bila namenjena ocenjevanju diagnostične učinkovitosti zdravila Amyvid za ugotavljanje gostote kortikalnih nevritičnih leh (njihovo odsotnost ali redkost v primerjavi z zmerno ali pogosto prisotnostjo).
Left to right panels show sagittal, coronal, and transverse PET image slices.
Slike od leve proti desni prikazujejo PET-posnetke sagitalne, koronarne in transverzalne rezine.
The average cortical to cerebellar SUVR values in AD patients show continual substantial increases from time zero through 30 minutes post-administration, with only small changes thereafter up to 90 minutes post-injection.
Povprečne vrednosti SUVR med skorjo in malimi možgani kažejo precejšnja neprekinjena povečanja od časa nič do 30 minut po dajanju, po tem in do 90
Administration of Amyvid and conduct of the procedure Amyvid is given as an injection into your vein (intravenous injection) followed by a flush of sodium chloride solution to ensure full delivery of the dose.
Dajanje zdravila Amyvid in izvedba postopka Zdravilo Amyvid se daje z injekcijo v veno (intravenska injekcija), ki ji sledi spiranje z raztopino natrijevega klorida, s čimer se zagotovi injiciranje celotnega odmerka.
Amyvid is a radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment.
Zdravilo Amyvid je radiofarmak, indiciran za slikanje gostote β-amiloidnih nevritičnih leh s pozitronsko emisijsko tomografijo (PET - Positron Emission Tomography) v možganih odraslih bolnikov s kognitivno motnjo, pri katerih se ugotavlja Alzheimerjeva bolezen (AB) in drugi vzroki kognitivne motnje.
For cases in which there is uncertainty about the location of grey matter and of the grey/white matter border on the PET scan, and a co-registered recent CT or MR image is available, the interpreter should examine the fused PET-CT or PET-MR image to clarify the relationship of the PET radioactivity and the grey matter anatomy.
V primeru negotovosti glede lokacije sive možganovine in roba med sivo in belo možganovino na PET-posnetku in ko je na voljo nedavna sočasna CT- ali MR-slika, naj razlagalec pregleda združeni PET-CT- oziroma PET-MR-sliki, da razjasni odnos med radioaktivnostjo pri PET in anatomijo sive možganovine.
Diluted product must be used within 4 hours of dilution.
Razredčeno zdravilo morate uporabiti v štirih urah po redčenju.
After administration of Amyvid, you should
Po prejemu zdravila Amyvid se morate
In a longitudinal study, 142 subjects (clinically diagnosed as MCI, AD or cognitively normal) underwent baseline florbetapir (18F) PET scans, and were followed for 3 years to evaluate the relationship between Amyvid imaging and changes in diagnostic status.
Pri longitudinalni študiji je 142 preiskovancev (s klinično diagnozo zmerne kognitivne okvare, AB ali kognitivno normalnih) opravilo izhodiščno PET-preiskavo s florbetapirjem (18F), nato pa so jih tri leta spremljali in vrednotili zvezo med slikanjem z zdravilom Amyvid in spremembami statusa diagnoze.
Amyvid must not be used - if you are allergic to florbetapir (18F) or any of the other ingredients of this medicine (listed in section 6).
Kaj morate vedeti, preden boste uporabili zdravilo Amyvid Ne uporabljajte zdravila Amyvid: - če ste alergični na florbetapir (18F) ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
The bottom two arrows indicate areas of decreased grey-white contrast with increased cortical activity that is comparable to the activity in the adjacent white matter.
Spodnji dve puščici kažeta na zmanjšan sivo-beli kontrast s povečano kortikalno aktivnostjo, ki je primerljiva z aktivnostjo v sosednji beli možganovini.
The in vivo binding of florbetapir (18F) to other β-amyloid structures or other brain structures or receptors remains unknown.
Vezava florbetapirja (18F) na druge β-amiloidne strukture ali druge možganske strukture ali receptorje in vivo še ni znana.
Uptake has also been identified in some cases in extracerebral structures such as scalp, salivary glands, muscles and cranial bone.
V nekaterih primerih so privzem dokazali tudi v zunajmožganskih strukturah, kot so lasišče, žleze slinavke, mišice in lobanjska kost.
Radiation protection precautions in accordance with national regulations must therefore be taken.
Zaščita pred sevanjem mora biti v skladu z nacionalnimi predpisi.
Amyvid is given to adults with memory problems so that doctors can perform a type of brain scan, called a PET scan.
Zdravilo Amyvid se daje odraslim, ki imajo težave s spominom, da zdravniki lahko opravijo možgansko preiskavo, imenovano PET-preiskava.
In AD subjects, as in controls, there is low retention in cerebellum and hippocampus and high retention in pons and centrum semiovale.
Pri preiskovancih z AB in pri kontrolah je zadrževanje v malih možganih in hipokampusu majhno, v ponsu in centrumu semiovale pa veliko.
EXPIRY DATE EXP: ToC + 10 h
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA EXP: ToC + 10 h
If you have any further question on the use of Amyvid, please ask your nuclear medicine doctor who supervises the procedure.
Če imate dodatna vprašanja o uporabi zdravila Amyvid, se posvetujte z zdravnikom nuklearne medicine, ki nadzira postopek.
Amyvid may be diluted aseptically with sodium chloride 9 mg/mL (0.9%) solution for injection to a maximum dilution of 1:5.
Zdravilo Amyvid lahko aseptično redčite z 9 mg/ml (0,9 %) raztopino natrijevega klorida za injiciranje do največje razredčitve 1:5.
The cerebellum region should be examined to confirm the fit of the ROI and the level of grey/white contrast, which provides a standard for visual comparison to cortex.
Preglejte regijo malih možganov, da boste potrdili ujemanje regije zanimanja in ravni sivega/belega kontrasta, kar zagotavlja standard za vizualno primerjavo s korteksom.
Driving and using machines Amyvid will not affect your ability to drive or to use machines.
Vpliv na sposobnost upravljanja vozil in strojev Zdravilo Amyvid ne bo vplivalo na vašo sposobnost upravljanja vozil in strojev.
This medicine also contains up to 37 mg sodium per dose (as sodium ascorbate and sodium chloride).
Zdravilo vsebuje tudi do 37 mg natrija na odmerek (v obliki natrijevega askorbata in natrijevega klorida).
Their results closely paralleled the results obtained in the pivotal trial.
Njihovi rezultati so ustrezali rezultatom,
Radioactivity in urine is present as polar metabolites of florbetapir (18F).
Radioaktivnost v urinu je prisotna v obliki polarnih presnovkov florbetapirja (18F).
The basis for making a visual positive or negative determination should be reviewed: a.
Preglejte podlago za vizualno odločitev o pozitivnem ali negativnem posnetku.
Interpretation of Amyvid images
Interpretacija slik z zdravilom Amyvid
The following side effect of Amyvid is common (may affect up to 1 in 10 people): - headache
Naslednji neželeni učinek zdravila Amyvid je pogost (lahko se pojavi pri največ 1 od 10 bolnikov):
2.80 (95% CI: 1.88-4.18)
2,80 (95-odstotni IZ: 1,88-4,18)
Binding studies using traditional neuropathological staining methods in post-mortem AD brains demonstrated statistically significant (p < 0.0001) correlations between in vitro florbetapir (18F) binding and β-amyloid aggregate deposition.
Študije vezave, ki so uporabljale tradicionalne nevropatološke metode barvanja možganov z AB post mortem, so pokazale statistično značilno (p < 0,0001) povezavo med vezavo florbetapirja (18F) in vitro in odlaganjem β-amiloidnih skupkov.
Some scans may be difficult to interpret due to image noise, atrophy with a thinned cortical ribbon, or image blur, which could lead to interpretation errors.
Nekatere posnetke je zaradi šuma na sliki, atrofije s stanjšanim kortikalnim trakom ali zamegljenosti slike težko interpretirati, zato pri interpretaciji lahko pride do napak.
EXPIRY DATE EXP: ToC + 7.5 h
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA EXP: ToC + 7,5 h
In vitro binding studies have not shown interference of florbetapir (18F) binding to β-amyloid plaques in the presence of other common medicinal products taken by AD patients.
Študije vezave in vitro niso pokazale motenj pri vezavi florbetapirja (18F) na β-amiloidne lehe v prisotnosti drugih pogostih zdravil, ki jih jemljejo bolniki z AB.
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT ≤28500 MBq at ToC (see outer packaging)
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT ≤ 28500 MBq ob ToC (glejte zunanjo ovojnino).
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT ≤ 12000 MBq at ToC (see outer packaging)
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT ≤ 12000 MBq ob ToC (glejte zunanjo ovojnino).
Advanced Accelerator Applications, 62660, Beuvry, France Advanced Accelerator Applications, 01630, Saint Genis Pouilly, France
Advanced Accelerator Applications, 62660, Beuvry, Francija Advanced Accelerator Applications, 01630, Saint Genis Pouilly, Francija
The pharmacokinetics of florbetapir (18F) in patients with renal or hepatic impairment have not been characterised.
Farmakokinetika florbetapirja (18F) pri bolnikih z ledvično ali jetrno okvaro ni bila določena.
Excipients with known effect Each mL of solution contains 79 mg of ethanol and each dose contains up to 37 mg of sodium.
En mililiter raztopine vsebuje 79 mg etanola in en odmerek vsebuje do 37 mg natrija.
Careful consideration of the benefit risk ratio in these patients is required since an increased radiation exposure is possible.
Okvara ledvic in jeter Pri teh bolnikih je treba skrbno pretehtati razmerje med koristmi in tveganji, saj je mogoča večja izpostavljenost sevanju.
This medicine contains 10 vol% ethanol (alcohol), i.e. up to 790 mg per dose, equivalent to 20 mL beer or 8 mL wine.
Zdravilo vsebuje 10 vol % etanola (alkohola), tj. do 790 mg na odmerek, kar ustreza 20 ml piva ali 8 ml vina.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska
Amyvid is supplied in 10 mL or 15 mL clear Type I borosilicate glass vials with FluroTec-coated chlorobutyl elastomeric stoppers and aluminium seals.
Zdravilo Amyvid je na voljo v 10 ml ali 15 ml prozornih vialah iz borosilikatnega stekla tipa I z zamaškom iz klorobutilnega elastomera, prevlečenega s FluroTec, in aluminijasto zaporko.
An Amyvid PET scan can help your doctor determine whether or not you may have β-amyloid plaques in your brain.
PETpreiskava z zdravilom Amyvid lahko vašemu zdravniku pomaga ugotoviti, ali imate v možganih βamiloidne lehe.
The dose is administered by intravenous bolus injection, followed by a flush of sodium chloride 9 mg/mL (0.9%) solution for injection to ensure full delivery of the dose.
Odmerek se daje z intravensko injekcijo v bolusu, ki ji sledi spiranje z 9 mg/ml (0,9 %) raztopino natrijevega klorida za injiciranje, s čimer se zagotovi injiciranje celotnega odmerka.
Pharmacotherapeutic group: diagnostic radiopharmaceutical, central nervous system, ATC code:
Farmakoterapevtska skupina: radiodiagnostiki za ugotavljanje bolezni osrednjega živčevja, oznaka ATC: V09AX05
Using non-MCI cases (cognitively normal & clinical AD)
Z uporabo primerov brez zmerne kognitivne okvare (kognitivno normalni in klinična AB)
You must stop breast-feeding for 24 hours after the injection and the maternal milk pumped must be discarded.
Dojenje morate po injiciranju prekiniti za 24 ur, izčrpano materino mleko pa zavreči.
Positive likelihood ratio 1.20 (95% CI: 0.76-1.91)
1,20 (95-odstotni IZ: 0,76-1,91)
In this assay, florbetapir did not increase the number of micronucleated polychromatic erythrocytes at the highest achievable dose level, 372 µg/kg/day, when given twice daily for 3 consecutive days.
Pri tem testu florbetapir v največjem dosegljivem odmerku, 372 µg/kg/dan, ki so ga dajali dvakrat na dan tri dni zaporedoma, ni povečal števila mikronukleusnih polikromatičnih eritrocitov.
This medicinal product contains 10 vol % ethanol (alcohol), i.e. up to 790 mg per dose, equivalent to 20 mL beer or 8 mL wine per dose.
Zdravilo vsebuje 10 vol % etanola (alkohola), tj. do 790 mg na odmerek, kar ustreza 20 ml piva ali 8 ml vina na odmerek.
It is supplied in a 10 mL or 15 mL clear glass vial.
Na voljo je v 10- ali 15-mililitrski stekleni viali iz prozornega stekla.
No differences in SUVR results were noted in subjects taking common AD treatments relative to those not taking AD treatments.
Rezultati SUVR pri preiskovancih, ki so jemali pogosta zdravila za AB, se v primerjavi s preiskovanci, ki zdravil za AB niso jemali, niso razlikovali.
Stomach wall
Stena želodca
The top two arrows are pointing to normal preserved grey-white contrast with the cortical activity less than the adjacent white matter.
Zgornji dve puščici kažeta na normalno ohranjen sivo-beli kontrast s kortikalno aktivnostjo, ki je nižja kot v sosednji beli možganovini.
Marketing Authorisation Holder Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands
Imetnik dovoljenja za promet z zdravilom Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska
Adjunctive use of amyloid PET quantitative information should only be used by readers trained in the application of quantitative information to aid visual image interpretation, including recommendations for selection of appropriate software to support the methods.
Dodatna uporaba kvantitativnih podatkov za interpretacijo posnetkov: Dodatna uporaba kvantitativnih podatkov o amiloidih pri PET-preiskavi naj bo omogočena le odčitovalcem, ki so usposobljeni za uporabo kvantitativnih podatkov v podporo interpretaciji vidnih posnetkov, vključno s priporočili za ustrezno programsko opremo, ki te metode podpira.
Examination of sagittal images and co-registered CT or MR images could help to distinguish occipital bone from occipital grey matter.
Pregled sagitalnih slik in sočasno posnetih CT- ali MR-slik lahko pomaga pri ločevanju med zatilnico in okcipitalno sivo možganovino.
When in doubt, it is important to consult your nuclear medicine doctor who will supervise the procedure.
Če ste v dvomih, je pomembno, da se posvetujte z zdravnikom nuklearne medicine, ki bo postopek nadzoroval.
Of the 17 MCI patients who had a positive PET scan, 6 (35%) were diagnosed with clinical probable AD 36 months later compared to 3 (10%) of 30 who had a negative scan.
mesecev pozneje 9 (19 %) prešlo v klinično AB. Od 17 bolnikov z zmerno kognitivno okvaro, ki so imeli pozitiven rezultat PET-preiskave, jih je 36 mesecev pozneje 6 (35 %) dobilo diagnozo klinično verjetne
If the integrity of the vial is compromised, the product should not be used.
Če je integriteta viale ogrožena, zdravila ne smete uporabiti.
Using non-AD cases (cognitively normal & MCI)
Z uporabo primerov brez AB (kognitivno normalni in z zmerno kognitivno okvaro)
Florbetapir (18F) is very rapidly cleared from circulation post-intravenous injection.
Razpolovni čas Florbetapir (18F) se po intravenskem injiciranju zelo hitro očisti iz obtoka.
Florbetapir (18F) is distributed throughout the body within several minutes of injection, and then is rapidly metabolised.
Porazdelitev Florbetapir (18F) se v nekaj minutah po injiciranju porazdeli po celem telesu, nato pa se hitro presnovi.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology and single and repeated dose toxicity, in which florbetapir [the non-radioactive form of florbetapir (18F)] was used.
Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri enkratnem in ponavljajočih se odmerkih, pri katerih je bil uporabljen florbetapir [neradioaktivna oblika florbetapirja
Fluorine (18F) decays to stable oxygen (18O) with a half-life of approximately 110 minutes by emitting a positron radiation of 634 keV, followed by photonic annihilation radiation of 511 keV.
Fluor (18F) z oddajanjem pozitronskega sevanja s 634 keV, čemur sledi fotonsko anihilacijsko sevanje s
You must inform the nuclear medicine doctor before you are given Amyvid if there is a possibility you might be pregnant, if you have missed your period or if you are breast-feeding.
Preden boste dobili zdravilo Amyvid, se posvetujte z zdravnikom nuklearne medicine, če obstaja možnost, da ste noseči, če vam zamuja menstruacija ali če dojite.
- If you have any further questions, ask your nuclear medicine doctor who will supervise the procedure.
- Če imate dodatna vprašanja, se posvetujte z zdravnikom nuklearne medicine, ki bo nadziral postopek.
Skin and subcutaneous tissue disorders
Bolezni kože in podkožja pruritus urtikarija
6.6 Special precautions for disposal and other handling
6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Splošna opozorila
As the effective dose is 7 mSv when the recommended activity of 370 MBq of florbetapir (18F) is administered, these adverse reactions are expected to occur with low probability.
Ker je pri aplikaciji priporočene aktivnosti 370 MBq florbetapirja (18F) učinkoviti odmerek 7 mSv, je možnost za pojav teh neželenih učinkov majhna.
(95% CI: 68.2-83.5%)
(95-odstotni IZ: 68,2-83,5 %)
Amyvid has no or negligible influence on the ability to drive and use machines.
4.7 Vpliv na sposobnost vožnje in upravljanja s stroji Zdravilo Amyvid nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
A 10 minute PET image should be acquired starting approximately 30 to 50 minutes after intravenous injection of Amyvid.
Slikanje Desetminutno slikanje s PET začnite približno 30 do 50 minut po intravenskem injiciranju zdravila
It should be taken into account in pregnant or breast-feeding women and high-risk groups such as patients with liver disease or epilepsy.
Vsebnost etanola upoštevajte tudi pri nosečnicah in doječih materah ter pri ogroženih skupinah, kot so bolniki z jetrnimi boleznimi ali epilepsijo.